Endogenous cannabinoid ligands--chemical and biological studies

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Arachidonic acid ethanolamide (anandamide) is a key brain lipid that interacts with cannabinoid receptors.
• Cannabinoid receptors (CB1 and CB2) are involved in various physiological processes.
• Delta 9-tetrahydrocannabinol (delta 9-THC) shares pharmacological effects with anandamide.

Purpose of the Study:

• To identify and characterize endogenous ligands for cannabinoid receptors.
• To investigate the physiological roles of anandamides and related compounds.
• To explore the developmental aspects of cannabinoid receptor function.

Main Methods:

• Identification of fatty acid ethanolamides and 2-arachidonyl-glycerol in biological tissues.
• Assessment of receptor binding and adenylate cyclase inhibition.
• Evaluation of behavioral responses (ambulation, analgesia) in relation to age.

Main Results:

• Anandamide, homo-gamma-linolenylethanolamide, and docostetraenylethanolamide bind to CB1 receptors.
• 2-arachidonyl-glycerol binds to both CB1 and CB2 receptors and affects spleen cells.
• Anandamide's effects on ambulation and analgesia are age-dependent, linked to CB1 receptor concentration.
• CB2 receptors are found in the spleen, and 2-arachidonyl-glycerol may modulate immune responses.

Conclusions:

• Anandamides are endogenous modulators involved in motor control and short-term memory.
• Age-related changes in CB1 receptor concentration influence anandamide's effects, with pediatric implications.
• A novel class of fatty acid amides and esters acts as chemical modulators in the body, impacting neurological and immune functions.